Bristol-Myers Squibb Company (BMY)

業務介紹

布里斯托-邁爾斯·斯奎布公司在全球範圍內發現、開發、許可、製造和銷售生物製藥產品。它提供用於血液病學、腫瘤學、心血管疾病、免疫學、纖維化、神經科學和COVID-19疾病的產品。該公司的產品包括Revlimid(用於治療多發性骨髓瘤的口服免疫調節藥物)、Eliquis(用於降低非瓣膜性心房顫動患者中風/全身性栓塞風險,以及用於治療深靜脈血栓/肺栓塞)、Opdivo(用於抗癌適應症)、Pomalyst/Imnovid(適用於多發性骨髓瘤患者)和Orencia(用於成人活動性類風濕性關節炎和銀屑病性關節炎患者)。它還提供Sprycel(用於治療菲拉德爾菲亞染色體陽性慢性髓性白血病)、Yervoy(用於治療不可切除或轉移性黑色素瘤患者)、Abraxane(一種蛋白結合化療產品)、Reblozyl(用於治療成人β地中海貧血患者的貧血)和Empliciti(用於治療多發性骨髓瘤)。此外,該公司還提供Zeposia(用於治療復發性多發性硬化症)、Breyanzi(一種CD19定向基因改造自體T細胞免疫療法,用於治療成人復發或難治性大B細胞淋巴瘤)、Inrebic(一種用於治療成人骨髓纖維化的口服激酶抑制劑)和Onureg(用於治療成人急性髓性白血病)。該公司將產品銷售給批發商、分銷商、藥房、零售商、醫院、診所和政府機構。該公司曾用名布里斯托-邁爾斯公司,成立於1887年,總部位於紐約。



Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

公司網址

https://www.bms.com